Loading
Latest filing published 15 Apr 2026 for Genprex, Inc., €8.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Brent M. Longnecker discloses dealings in 3 companies, chiefly AmREIT, Inc., ATP Oil & Gas Corp and Genprex, Inc. The record holds 40 filings, for trades running from 24 November 2009 to 14 April 2026.
The open-market side counts 19 purchases for €508k alongside 3 sales for €134k. Purchases outweigh sales by €375k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 13 share grants. In 2026 alone, the filings show no purchases and 2 sales.
The median purchase comes to €15k.
On 15 April 2026 came the latest disclosure, an open-market sale for €10 in Genprex, Inc. The last insider purchase was made public on 7 April 2021, 2,025 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations